Physician profile
Michael J Rivero
NPI 1831337492
$1,095.63
in general payments reported to CMS, 2019-2025
13 companies · $388 in 2025
The $388 reported for 2025 was more than what 76% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $199 · 2020: $22.76 · 2021: $152 · 2022: $50.74 · 2023: $245 · 2024: $37.88 · 2025: $388.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $671.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $671.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $496.62 | 2019-2025 | Indigo System, Ruby Coil |
| Stryker Corporation | $212.91 | 2025 | Flowtriever, Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Okami Medical, INC. | $79.03 | 2021-2023 | Lobo |
| Argon Medical Devices, INC. | $72.26 | 2019-2022 | |
| Inari Medical, INC. | $64.74 | 2019-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Medtronic, INC. | $45.56 | 2021 | |
| Medtronic Vascular, INC. | $30.00 | 2019 | |
| Cordis US Corp. | $25.18 | 2023 | Mynxgrip |
| Angiodynamics, INC. | $22.76 | 2020 | |
| Chiesi USA, INC. | $18.16 | 2021 | |
| Bard Peripheral Vascular, INC. | $15.28 | 2023 | Set Aspirex S 10f 110cm |
| W. L. Gore & Associates, INC. | $13.13 | 2023 | Gore Viatorr Tips Endoprosthesis |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Rivero listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.